EUVIMEDEUVIMED entdecken
Crossref

The Synergistic Anticancer Effect of Pitavastatin and Metformin Against BT-20 Breast Cancer Cell Line Types

Nader N. Alnahhal, Mohammed A. Adris, Saeb H. Aliwaini, Akram M. Altaher

Israa University Journal for Applied Science · 2025

DOI: 10.52865/fbtv6754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Israa University Journal for Applied Science, 2025. Verfasst von Nader N. Alnahhal und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer ranks second in terms of all malignancies worldwide, making it one of the most common cancers. Treatment efforts for breast cancer have several disadvantages, including cytotoxic side effects and multidrug resistance. As a result, a shift toward more effective drugs with fewer side effects is required. Studies have recently demonstrated the efficacy of both Pitavastatin and Metformin against cancer cells, and we found that their combination has a significant influence against breast cancer cells when compared to utilizing either drug alone.

Methods

The cytotoxicity of Metformin and Pitavastatin on BT-20 breast cancer cells was evaluated using the MTT test. A trypan blue assay was used to evaluate the combined treatment's anti-proliferative effects.

Results

According to the study's findings, BT-20 cell viability was decreased by pitavastatin and metformin treatments alone in a concentration- and time-dependent manner. However, combining the two drugs resulted in a greater antiproliferative impact on BT-20 cells. Trypan blue results showed that combination drugs kill BT-20 cells more than single treatments.

Conclusion

The results suggest that the combination of Pitavastatin and Metformin has a synergistic anticancer effect against BT-20 breast cancer cells.

Zitieren

APA

Alnahhal, N. N., Adris, M. A., Aliwaini, S. H., & Altaher, A. M. (2025). The Synergistic Anticancer Effect of Pitavastatin and Metformin Against BT-20 Breast Cancer Cell Line Types. Israa University Journal for Applied Science. https://doi.org/10.52865/fbtv6754

Vancouver

Alnahhal NN, Adris MA, Aliwaini SH, Altaher AM. The Synergistic Anticancer Effect of Pitavastatin and Metformin Against BT-20 Breast Cancer Cell Line Types. Israa University Journal for Applied Science. 2025. doi:10.52865/fbtv6754

BibTeX
@article{Alnahhal2025,
  author = {Alnahhal, Nader N. and Adris, Mohammed A. and Aliwaini, Saeb H. and Altaher, Akram M.},
  title = {The Synergistic Anticancer Effect of Pitavastatin and Metformin Against BT-20 Breast Cancer Cell Line Types},
  journal = {Israa University Journal for Applied Science},
  year = {2025},
  doi = {10.52865/fbtv6754}
}
Kostenlos starten →